NewGenIvf Group Limited

NewGenIvf Group Limited

NIVFW
NewGenIvf Group LimitedUS flagNASDAQ Capital Market
0.04
USD
- -
- -
79,583.00Market Cap
NewGenIvf Group Limited
NIVFW
(NASDAQ Capital Market)

Recent

price

0.04

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
FRC
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
4
6
5
5
5
Sales/Revenue/Turnover
4.83
6.71
0.82
-21.36
-226.95
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
-1
10
Net Income, GAAP
188.7
60.51
- -
- -
- -
Effective Tax Rate (%)
-0.01
7.72
2.53
-9.66
209.02
Profit Margin (%)
-1
- -
1
- -
5
Working Capital
- -
- -
- -
2
4
LT Debt
-1
- -
3
-1
26
Total Equity
- -
22.02
1.63
- -
-66.18
Return on Invested Capital (%)
- -
-190.31
-32.62
- -
144.62
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-1,853.78%
Free Cash Flow
- -
- -
100.5%
Net Income, GAAP
- -
- -
-1,983.07%
Sales/Revenue/Turnover
- -
- -
-13.01%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5
2024
1
1
- -
- -
5
2025
- -
1
1
- -
5

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
NewGenIvf Group Limited (NASDAQ: NIVFW) operates as a fertility services provider offering comprehensive in vitro fertilization (IVF) treatments and related reproductive health solutions. The company delivers core services including IVF cycles, intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), embryo freezing and storage, egg donation programs, and surrogacy arrangements; it also provides ancillary offerings such as fertility consultations, andrological assessments, and advanced reproductive technologies through its network of clinics. Headquartered in Hong Kong and founded in 2018, NewGenIvf serves patients across Asia-Pacific markets including Hong Kong, mainland China, and Southeast Asia, targeting individuals and couples seeking assisted reproductive technologies. In recent developments within the last two years, the company has expanded its clinic footprint through strategic clinic openings in key urban centers and formed alliances with regional healthcare providers to enhance service accessibility; it completed a Nasdaq listing via a SPAC merger in 2023, securing funding for operational growth and technology upgrades in its laboratories.